The Basics

What Is Non-Hodgkin's Lymphoma?

This content has been reviewed and approved by
James O. Armitage, MD
The Joe Shapiro Professor of Internal Medicine
Section of Oncology/Hematology
University of Nebraska Medical Center


If you've received a diagnosis of lymphoma, you should know that you are not alone. Lymphomas are the fifth most common type of cancer in the United States, excluding nonmelanoma skin cancer, according to the American Cancer Society (ACS).

The ACS also estimates that you have a 1 in 50 chance of getting non-Hodgkin’s lymphoma sometime in your life. The disease occurs overwhelmingly in adults, with the average age at diagnosis between 60 and 70. However, the disease can occur in any age group. Although children rarely get cancer, approximately 15 percent of childhood cancers are lymphomas.

As stated above non-Hodgkin’s lymphomas are cancers of lymphocytes (a type of white blood cell). Lymphocytes can be subdivided into B cells, which are primarily involved in the production of antibodies (disease fighters), and T cells, which carry out a complicated set of tasks, including modulating the immune system response.

To carry out their functions, lymphocytes are found throughout the body. They are primarily produced in the bone marrow (produces blood cells) and lymph nodes in adults, but also circulate in the blood and are found in other organs in the body. Thus, lymphomas can originate at any site in the body.

In the United States, almost 90 percent of lymphomas originate in B cells. The remainder of lymphomas originate in T cells or NK cells (a specialized subset of T cells). In other parts of the world, the proportion of lymphomas originating in T cells can be much higher.

The non-Hodgkin’s lymphomas are a variety of different cancers—not just one disease. In the past 10 to 20 years, it has become apparent that accurate diagnosis of the specific type of lymphoma is necessary for the best care. Different lymphomas have different clinical patterns, and all do not respond optimally to the same treatments.

What Is Lymphoblastic Lymphoma?

Lymphoblastic lymphomas are tumors of immature lymphocytes that have not yet become mature T cells or B cells. Cancers of these cells frequently manifest as acute lymphoblastic leukemia. However, these malignancies can present as lymphomas with enlarged lymph nodes as the major manifestation. A characteristic finding is a large mass in the mediastinum (space between the lungs) in a young man. These are rapidly growing malignancies, but very responsive to treatment.

This content was last modified on August 15, 2007 .

Latest Non-Hodgkin's Lymphoma News

  • May 14, 2008
    Smoking and Heavy Alcohol Consumption Reduce Survival in Non-Hodgkin's Lymphoma
    Patients diagnosed with non-Hodgkin’s lymphoma (NHL) who smoke tobacco products and/or drink large quantities of alcohol have a reduced chance of optimal survival. These results were recently published in the International Journal of Cancer.
  • May 8, 2008
    Worse Prognosis for “Bulky” Disease Diffuse Large B-Cell Lymphoma
    Young patients with diffuse large-B-cell lymphoma (DLBCL) with cancerous masses that are 10.0 centimeters or greater in diameter are considered to have “bulky” disease and have a worse prognosis than those with smaller masses. These findings were published in Lancet Oncology.
  • May 5, 2008
    Treanda® Included in NCCN Guidelines for CLL and NHL
    The chemotherapy agent Treanda® (bendamustine) has been added to the treatment guidelines of the National Comprehensive Cancer Network (NCCN) as an accepted treatment option for chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma (NHL).
Select news items provided by Reuters Health
More Cancer News

Privacy Policy reviewed by TRUSTe

This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health
Information:
verify here.

Secure transactions for this website use a thawte certificate to ensure secure transmission of your information.